GCG and chronic kidney disease: In addition, given the burden of CKD among patients with T2D and the difficulties in treating such patients, in the current study we also explored the association between initiation of therapy with a GLP-1 RA and changes in glycated hemoglobin (A1c) and kidney function, as measured by the eGFR.